Marshall Wace, LLP Madrigal Pharmaceuticals, Inc. Transaction History

Marshall Wace, LLP

$78.4 Billion
Q4 2024

A detailed history of Marshall Wace, LLP transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 17,494 shares of MDGL stock, worth $5.88 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,494

Previous 80,401 78.24%

Holding current value

$5.88 Million

Previous $17.1 Million 68.36%

% of portfolio

0.01%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$202.45 - $354.85 $12.7 Million - $22.3 Million	-62,907 Reduced 78.24%	17,494 $5.4 Million
Q3 2024 Nov 14, 2024	BUY	$212.22 - $292.96 $16.7 Million - $23.1 Million	78,701 Added 4629.47%	80,401 $17.1 Million
Q2 2024 Aug 14, 2024	BUY	$193.33 - $291.99 $328,661 - $496,383	1,700 New	1,700 $476,000
Q4 2023 Feb 14, 2024	SELL	$120.4 - $237.13 $43.6 Million - $85.9 Million	-362,327 Reduced 91.64%	33,071 $7.65 Million
Q3 2023 Nov 14, 2023	SELL	$146.04 - $225.78 $9.53 Million - $14.7 Million	-65,246 Reduced 14.16%	395,398 $57.7 Million
Q2 2023 Aug 14, 2023	SELL	$203.88 - $312.0 $16.5 Million - $25.3 Million	-81,120 Reduced 14.97%	460,644 $106 Million
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $125 Million - $166 Million	541,764 New	541,764 $131 Million
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $33,981 - $61,949	-608 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$72.34 - $95.09 $7.06 Million - $9.28 Million	-97,572 Reduced 99.38%	608 $52,000
Q2 2021 Aug 13, 2021	BUY	$97.2 - $137.59 $9.54 Million - $13.5 Million	98,180 New	98,180 $9.56 Million
Q1 2020 May 15, 2020	SELL	$66.76 - $93.49 $90,126 - $126,211	-1,350 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$84.28 - $118.5 $57,816 - $81,291	-686 Reduced 33.69%	1,350 $123,000
Q3 2019 Nov 14, 2019	BUY	$84.4 - $106.53 $171,838 - $216,895	2,036 New	2,036 $175,000
Q2 2019 Aug 14, 2019	SELL	$91.13 - $142.5 $1.86 Million - $2.92 Million	-20,462 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$103.48 - $143.84 $2.12 Million - $2.94 Million	20,462 New	20,462 $2.56 Million
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $1.88 Million - $4.27 Million	-19,808 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$207.3 - $300.31 $4.11 Million - $5.95 Million	19,808 New	19,808 $4.24 Million

Others Institutions Holding MDGL

# of Institutions

335

Shares Held

22.3M

Call Options Held

960K

Put Options Held

940K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.75B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Madrigal Pharmaceuticals, Inc. Transaction History